CoChat

In vivo base editing of post-mitotic sensory cells

Open access

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

Programmable nucleases can introduce precise changes to genomic DNA through homology-directed repair (HDR). Unfortunately, HDR is largely restricted to mitotic cells, and is typically accompanied by an excess of stochastic insertions and deletions (indels). Here we present an in vivo base editing strategy that addresses these limitations. We use nuclease-free base editing to install a S33F mutation in β-catenin that blocks β-catenin phosphorylation, impedes β-catenin degradation, and upregulates Wnt signaling. In vitro, base editing installs the S33F mutation with a 200-fold higher editing:indel ratio than HDR. In post-mitotic cells in mouse inner ear, injection of base editor protein:RNA:lipid installs this mutation, resulting in Wnt activation that induces mitosis of cochlear supporting cells and cellular reprogramming. In contrast, injection of HDR agents does not induce Wnt upregulation. These results establish a strategy for modifying posttranslational states in signaling pathways, and an approach to precision editing in post-mitotic tissues.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-04580-3

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Base editing strategy and comparison of HDR and base editing following plasmid delivery. a Schematic representation of the canonical Wnt pathway and a base editing strategy to stabilize β-catenin. In the absence of Wnt signaling, β-catenin is phosphorylated at Ser 33 by GSK-3β and degraded in a phosphorylation-dependent manner. Base editing with BE3 precisely mutates the Ser 33 codon to instead encode Phe, which cannot be phosphorylated. The resulting S33F β-catenin has an extended half-life and can activate target gene transcription by binding with TCF/LEF transcription factors. b HEK293T cells were transfected with plasmids expressing BE3 and S33-targeting sgRNA, or BE3 and an unrelated sgRNA. The percentage of total sequencing reads (with no enrichment for transfected cells) with C8 converted to T8 (resulting in the S33F mutation) was measured with high-throughput sequencing (HTS). c Plasmid delivery of Cas9 and BE3 (750 ng) with S33-targeting sgRNA (250 ng) into HEK293T cells using 1.5 µL of Lipofectamine 2000 per well of a 48-well plate. C-to-T conversion efficiency and d product selectivity ratio (desired S33F mutation: undesired indel ratio) resulting from the best-performing ratio of Cas9:sgRNA:ssDNA template and BE3. Values and error bars reflect mean ± S.E.M. of three biological replicates performed on separate days
Fig. 1 Base editing strategy and comparison of HDR and base editing following plasmid delivery. a Schematic representation of the canonical Wnt pathway and a base editing strategy to stabilize β-catenin. In the absence of Wnt signaling, β-catenin is phosphorylated at Ser 33 by GSK-3β and degraded in a phosphorylation-dependent manner. Base editing with BE3 precisely mutates the Ser 33 codon to instead encode Phe, which cannot be phosphorylated. The resulting S33F β-catenin has an extended half-life and can activate target gene transcription by binding with TCF/LEF transcription factors. b HEK293T cells were transfected with plasmids expressing BE3 and S33-targeting sgRNA, or BE3 and an unrelated sgRNA. The percentage of total sequencing reads (with no enrichment for transfected cells) with C8 converted to T8 (resulting in the S33F mutation) was measured with high-throughput sequencing (HTS). c Plasmid delivery of Cas9 and BE3 (750 ng) with S33-targeting sgRNA (250 ng) into HEK293T cells using 1.5 µL of Lipofectamine 2000 per well of a 48-well plate. C-to-T conversion efficiency and d product selectivity ratio (desired S33F mutation: undesired indel ratio) resulting from the best-performing ratio of Cas9:sgRNA:ssDNA template and BE3. Values and error bars reflect mean ± S.E.M. of three biological replicates performed on separate daysCC BY · PubMed Central
Fig. 2 Biological outcomes associated with base editing S33F in β-catenin in human cells. a HEK293T cells were transfected with plasmids encoding Topflash (β-catenin-responsive firefly luciferase reporter) or Fopflash (mutant form of Topflash that cannot be activated by β-catenin) and mutant S33F β-catenin or wild-type (Ser 33) β-catenin. Wnt signaling was measured by the ratio of Topflash:Fopflash luciferase activity. b Cytosolic and nuclear extracts of HEK293T cells treated with base editor and S33-targeting sgRNA or unrelated sgRNA were subjected to western blot analysis for total β-catenin or non-phosphorylated β-catenin (Ser33/Ser37/Thr41). Each blot represents one antibody. GAPDH was used as a loading control. c HEK293T cells were transfected with plasmids encoding the Topflash or Fopflash reporters, base editor, and S33F or unrelated control sgRNA. The Topflash:Fopflash luciferase ratio for BE3 + S33-targeting sgRNA (blue) and BE3 + unrelated sgRNA (red) are shown. d Percent C-to-T conversion at the target Ser 33 codon, which results in the S33F mutation in β-catenin, assayed by HTS. Values and error bars reflect mean ± S.E.M. of three biological replicates performed on different days. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, and **** p ≤ 0.0001 (Student’s two tailed t-test)
Fig. 2 Biological outcomes associated with base editing S33F in β-catenin in human cells. a HEK293T cells were transfected with plasmids encoding Topflash (β-catenin-responsive firefly luciferase reporter) or Fopflash (mutant form of Topflash that cannot be activated by β-catenin) and mutant S33F β-catenin or wild-type (Ser 33) β-catenin. Wnt signaling was measured by the ratio of Topflash:Fopflash luciferase activity. b Cytosolic and nuclear extracts of HEK293T cells treated with base editor and S33-targeting sgRNA or unrelated sgRNA were subjected to western blot analysis for total β-catenin or non-phosphorylated β-catenin (Ser33/Ser37/Thr41). Each blot represents one antibody. GAPDH was used as a loading control. c HEK293T cells were transfected with plasmids encoding the Topflash or Fopflash reporters, base editor, and S33F or unrelated control sgRNA. The Topflash:Fopflash luciferase ratio for BE3 + S33-targeting sgRNA (blue) and BE3 + unrelated sgRNA (red) are shown. d Percent C-to-T conversion at the target Ser 33 codon, which results in the S33F mutation in β-catenin, assayed by HTS. Values and error bars reflect mean ± S.E.M. of three biological replicates performed on different days. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, and **** p ≤ 0.0001 (Student’s two tailed t-test)CC BY · PubMed Central
Fig. 3 Comparison of efficiency and product selectivity of HDR vs. base editing following RNP delivery. RNP delivery into HEK293T cells of 200 nM Cas9 or 200 nM BE3 pre-complexed with the S33-targeting sgRNA or an unrelated sgRNA and delivered in a cationic liposome. a Frequency of S33F mutation (blue) and indels (green) from treatment with CORRECT HDR agents (Cas9, sgRNA, and ssDNA donor template) in the ratios shown. b Product selectivity ratio, defined as the ratio of S33F modification to indel modification, resulting from treatment with the CORRECT HDR agents used in a. c Comparison of target C to T conversion efficiency following RNP delivery of BE3 (blue) or CORRECT HDR (purple) and the S33-targeting sgRNA. The control corresponds to cells treated with BE3 protein and unrelated sgRNA. d Product selectivity of base editing and CORRECT HDR. Values and error bars reflect mean ± S.E.M. of three independent biological replicates performed on different days
Fig. 3 Comparison of efficiency and product selectivity of HDR vs. base editing following RNP delivery. RNP delivery into HEK293T cells of 200 nM Cas9 or 200 nM BE3 pre-complexed with the S33-targeting sgRNA or an unrelated sgRNA and delivered in a cationic liposome. a Frequency of S33F mutation (blue) and indels (green) from treatment with CORRECT HDR agents (Cas9, sgRNA, and ssDNA donor template) in the ratios shown. b Product selectivity ratio, defined as the ratio of S33F modification to indel modification, resulting from treatment with the CORRECT HDR agents used in a. c Comparison of target C to T conversion efficiency following RNP delivery of BE3 (blue) or CORRECT HDR (purple) and the S33-targeting sgRNA. The control corresponds to cells treated with BE3 protein and unrelated sgRNA. d Product selectivity of base editing and CORRECT HDR. Values and error bars reflect mean ± S.E.M. of three independent biological replicates performed on different daysCC BY · PubMed Central
Fig. 4 Outcomes associated with in vivo RNP-mediated base editing in post-mitotic cochlea. a The cochlea of a postnatal day 1 (P1) mouse was injected with lipid nanoparticles encapsulating BE3 + sgRNA, CORRECT HDR agents, or controls. The next day, mice received 5-ethynyl-2-deoxyuridine (EdU) by subcutaneous injection once per day for 5 days. At postnatal day 7 (P7), one day after the fifth EdU injection, the cochlea was dissected and organ of Corti was visualized by chemical staining (to visualize EdU) and immunofluorescence (Myo7a and Sox2). In the cochlea, Myo7a (red) is expressed in hair cells and Sox2 (green) is expressed in supporting cells. EdU (white) marks newly divided cells. b Quantification of Sox2 and EdU double-positive cells at the apical region of the organ of Corti from mice treated with BE3 + S33-targeting sgRNA (n = 3), CORRECT HDR agents (n = 3), or BE3 + unrelated sgRNA (n = 3). Values and error bars reflect mean and S.E.M. c–n Images from the organ of Corti tissue of mice treated with BE3 + unrelated sgRNA (c, f, i, j); CORRECT HDR agents (d, g, k, l); or BE3 + S33-targeting sgRNA (e, h, m, n). The blue arrows point to triple-positive cells that had undergone proliferation and reprogramming to cells expressing Myo7a. c–e x–y plane of hair cell layers. f–h x–y plane of supporting cell layers. (i, k, m) x–z plane of samples in f, g, h at the dotted yellow lines. j, k, m x–z plane of samples in f, g, h at the dotted yellow lines, but with the Myo7a and Sox2 channels shown. Scale bar (white) = 25 μm
Fig. 4 Outcomes associated with in vivo RNP-mediated base editing in post-mitotic cochlea. a The cochlea of a postnatal day 1 (P1) mouse was injected with lipid nanoparticles encapsulating BE3 + sgRNA, CORRECT HDR agents, or controls. The next day, mice received 5-ethynyl-2-deoxyuridine (EdU) by subcutaneous injection once per day for 5 days. At postnatal day 7 (P7), one day after the fifth EdU injection, the cochlea was dissected and organ of Corti was visualized by chemical staining (to visualize EdU) and immunofluorescence (Myo7a and Sox2). In the cochlea, Myo7a (red) is expressed in hair cells and Sox2 (green) is expressed in supporting cells. EdU (white) marks newly divided cells. b Quantification of Sox2 and EdU double-positive cells at the apical region of the organ of Corti from mice treated with BE3 + S33-targeting sgRNA (n = 3), CORRECT HDR agents (n = 3), or BE3 + unrelated sgRNA (n = 3). Values and error bars reflect mean and S.E.M. c–n Images from the organ of Corti tissue of mice treated with BE3 + unrelated sgRNA (c, f, i, j); CORRECT HDR agents (d, g, k, l); or BE3 + S33-targeting sgRNA (e, h, m, n). The blue arrows point to triple-positive cells that had undergone proliferation and reprogramming to cells expressing Myo7a. c–e x–y plane of hair cell layers. f–h x–y plane of supporting cell layers. (i, k, m) x–z plane of samples in f, g, h at the dotted yellow lines. j, k, m x–z plane of samples in f, g, h at the dotted yellow lines, but with the Myo7a and Sox2 channels shown. Scale bar (white) = 25 μmCC BY · PubMed Central
Fig. 5 In vivo S33F mutation of β-catenin induced by injection of base editor RNPs. a Tissue was harvested from the cochlea of mice injected with either BE3 + S33-targeting sgRNA, or with CORRECT HDR agents. HTS of genomic DNA isolated from tissue samples revealed the frequency of the S33F mutation. Note that because tissue samples contain cells not exposed to editing agents, the observed genome modification frequency in these samples is less than the editing efficiency of treated cells. b Indel frequency at the Ser 33 locus following treatments described in a. Values and error bars reflect mean ± S.E.M. of four mice injected with BE3 and four mice injected with CORRECT HDR agents. Control samples in a, b are organ of Corti from three contralateral uninjected ears
Fig. 5 In vivo S33F mutation of β-catenin induced by injection of base editor RNPs. a Tissue was harvested from the cochlea of mice injected with either BE3 + S33-targeting sgRNA, or with CORRECT HDR agents. HTS of genomic DNA isolated from tissue samples revealed the frequency of the S33F mutation. Note that because tissue samples contain cells not exposed to editing agents, the observed genome modification frequency in these samples is less than the editing efficiency of treated cells. b Indel frequency at the Ser 33 locus following treatments described in a. Values and error bars reflect mean ± S.E.M. of four mice injected with BE3 and four mice injected with CORRECT HDR agents. Control samples in a, b are organ of Corti from three contralateral uninjected earsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Research works printed but not linked: 1

  1. Chadwick, A. C., Wang, X. & Musunuru, K. In vivo base editing of PCSK9 (proprotein convertase subtilisin/Kexin Type 9) as a therapeutic alternative to genome editing. Arterioscler. Thromb. Vasc. Biol. 37, 1741 (2017). · DOI · Paper page

Cited by

See all 240

Metadata

Authors
Yeh, W.-H., Chiang, H., Rees, H. A., Edge, A. S. B., & Liu, D. R.
Affiliations
  • Broad Institute (US)
  • Massachusetts Eye and Ear Infirmary (US)
Corresponding author
  • Edge, Albert S. B.
  • Liu, David R.
Venue
Nature Communications
Published
2018-06-05
Volume
9
Issue
1
Pages
2184-2184
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2805743335
Cited by
225
References
60
Citations by year
2026: 11 · 2025: 10 · 2024: 20 · 2023: 26 · 2022: 18 · 2021: 39 · 2020: 67 · 2019: 27 · 2018: 7
FWCI
12.54
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Howard Hughes Medical Institute
  • Harvard University
  • Shulsky Foundation
  • National Institutes of Health (NIH-R01, HR0011-17-2-0049)
  • Defense Advanced Research Projects Agency (HR0011, HR0011-17-2-0049)
  • National Human Genome Research Institute (RM1HG009490)
  • National Institute on Deafness and Other Communication Disorders (R01DC014089, R01DC007174)
  • National Institute of General Medical Sciences (R35GM118062)
  • National Institute of Biomedical Imaging and Bioengineering (R01EB022376)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
  • Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
Keywords
postmitotic cells, Wnt signaling, homology-directed repair, inner ear, cochlear supporting cells, cellular reprogramming, post-translational modification, precision genome editing
MeSH terms
Animals, Hair Cells, Auditory, Inner, Humans, Mice, Transgenic, Mitosis, Mutation, Mice, Knockout, NIH 3T3 Cells, beta Catenin, Mice, DNA Breaks, Double-Stranded, HEK293 Cells, Recombinational DNA Repair, Wnt Signaling Pathway

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In vivo base editing of post-mitotic sensory cells. https://app.cochat.ai/papers/10.1038/s41467-018-04580-3
The paper
Yeh, W.-H., Chiang, H., Rees, H. A., Edge, A. S. B., & Liu, D. R. (2018). In vivo base editing of post-mitotic sensory cells. Nature Communications. https://doi.org/10.1038/s41467-018-04580-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.